Actionable news
0
All posts from Actionable news
Actionable news in FN: FABRINET,

Hain Celestial, VipShop And 3 Others Stocks Moving After Hours

U.S. stock markets closed up on Monday, hitting record highs yet again, mostly helped by a spike in commodity-related stocks that was driven by a weaker U.S. dollar.

Fabrinet FN 4.21% announced Q4 EPS of $0.60, while revenue of $276.4 million beat expectations by $13.45 million. For the ongoing quarter, management expects revenue of $306 million to $310 million, versus estimates of $269 million, and EPS of $0.70 to $0.72. Shares traded up almost 4.9 percent in the after-hours session.

Vipshop Holdings Ltd – ADR VIPS 3.16% gained more than 3.35 percent. EPS of $0.17 beat the Street’s consensus by $0.02, while revenue of $2.02 billion, up 39.3 percent year-over-year, came in $120 million ahead of expectations.

Cesca Therapeutics Inc KOOL 6.06% was up more than 3.5 percent on the announcement that Empery Asset Management reported a 5.43 percent passive stake in the company. As per the 13G SEC filing, the firm 200,000 shares of Common Stock, worth roughly $870,000 at current valuations.

Pinnacle Entertainment Inc PNK 0.28% gained more than 4.75 percent after the bell rang. The rise followed the announcement of a new $50 million stock repurchase program.

Hain Celestial Group Inc HAIN 3.52% tumbled more than 24 percent to $40.46 after announcing it would delay the release of its financial results for the fourth quarter and full fiscal year 2016. The company needs to review if the revenue associated with certain concessions granted to U.S. distributors “was accounted for in the correct period.”

In addition, the firm said it's “currently evaluating its internal control over financial reporting. The Audit Committee of the Company's Board of Directors is conducting an independent review of these matters and has retained independent counsel to assist in that review." Moreover, management doesn't see the company achieving its previously announced guidance for the full year.

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.